new YORK (Reuters Health) – the newborn infants with

ischemic encephalopathy hypoxic ( EIH), whether it is severe or

moderate, to obtain better results if they are treated with

therapeutic hypothermia, shows a meta-analysis.

The discovery was kept even if the babies were handled

with cooling brain systemic or selective, said the

researchers.

“Doctors should be evaluated to provide therapeutic hypothermia

as part of these routine clinical care

born”, said the team of Canadian experts in an article

posted in Archives of Pediatrics and Adolescent Medicine.

El Dr. Mohamed a. Tagin, the Hospital for sick children

of Toronto, Ontario, and his colleagues claim that the

evidence to support hypothermia in the newborn infants with

EIH has been ambiguous. Recent reviews reported benefits

in the newborn infants with severe but not moderate encephalopathy

and vice-versa.

For this reason, experts conducted a systematic review

to assemble “all available information” and identified

seven and controlled trials randomised met all the

inclusion criteria.

Four trials used total body cooling and three,

selective head cooling compared to normothermia,

in a total of 1.214 newborn infants with moderate to severe EIH.

From the information collected, the proportion of

overall risk of death or major disability of the

neurodevelopment at 18 months was 0.76 with hipotermina,

compared to the normothermia, found the team. The

number-needed-try was 7 (seven).

In addition, hazard ratios were 0.75 with the

body cooling with selective cooling 0.77 and total

in the head, the report said. The benefit was extended to the

newborn infants with severe as those with EIH EIH

moderated.

Team also assessed the extent of risk of

disability and death separately.

“An important outcome of this review is that the

hypothermia reduced the mortality rate without increasing the rate of

disability in the asphyxiated infants”, indicated the

report. This was shown by a reduction in the rate of

important disability and an increase in the rate of

survival with normal neurological function.

. In conclusion, the doctor Tagin and colleagues commented that the

doctors should still be conservative in the advice of

parents on longer-term neurological function.

“Long-term follow-ups of the newborns in the

trials reported so far will provide data to examine

If the neurological information recorded 18 months predicts

a detailed neurological function in the long term”,

finished the authors.

The team added: “given that the result of suffocation to the

birth is devastadota, the work should continue to seek

adjuvant therapies to hypothermia”.

Source: Archives of Pediatrics and Adolescent Medicine,

online 6 February 2012